Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial by Low, Jenny G, MPH, Sung, Cynthia, PhD, Wijaya, Limin, MRCP, Wei, Yuan, MSc, Rathore, Abhay P S, MSc, Watanabe, Satoru, PhD, Tan, Boon Hian, BSc, Toh, Liying, BSc, Chua, Lian Tee, BSc, Hou, Yan'an, BSc, Chow, Angelia, Dip Sc, Howe, Shiqin, BSc, Chan, Wing Ki, BSc, Tan, Kah Hin, BSc, Chung, Jasmine S, MRCP, Cherng, Benjamin P, MRCP, Lye, David C, FRACP, Tambayah, Paul A, Prof, Ng, Lee Ching, PhD, Connolly, John, PhD, Hibberd, Martin L, Prof, Leo, Yee Sin, FRCP, Cheung, Yin Bun, Prof, Ooi, Eng Eong, FRCPath, Vasudevan, Subhash G, Prof

Get full text